TherapeuticsMD Inc (NASDAQ:TXMD)

5.95
Delayed Data
As of 4:00pm ET
 +0.10 / +1.71%
Today’s Change
3.83
Today|||52-Week Range
7.01
-1.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues4.3M4.4M4.1M3.8M
 
 
 
 
 
Cost of Goods Sold681.7K700.8K594.8K633.6K
 
 
 
 
 
Depreciation And Amortization53.2K54.1K56.2K59.6K
 
 
 
 
 
 
Operating ExpensesGross Income3.5M3.7M3.5M3.1M
 
 
 
 
 
General Expenses23.3M18.5M25.2M27.8M
 
 
 
 
 
Research And Development8.7M6.4M11.0M7.0M
 
 
 
 
 
Total Operating Expenses24.1M19.2M25.8M28.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.8M-14.8M-21.7M-24.7M
 
 
 
 
 
Other Expenses149.1K167.3K253.3K314.6K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.7M-14.7M-21.4M-24.4M
 
 
 
 
 
Net Income-19.7M-14.7M-21.4M-24.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS203.4M207.9M216.4M216.5M
 
 
 
 
 
Shares To Calculate EPS Diluted203.4M207.9M216.4M216.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.07-$0.10-$0.11
 
 
 
 
 
EPS Diluted-$0.10-$0.07-$0.10-$0.11